Tennr
AI platform automating referral intake, prior auths, and patient routing to cut denials and boost conversions for specialty providers.
Visit WebsiteOverview
Tennr is a document AI and patient orchestration platform — fundamentally different from the voice AI companies in this batch. The core product ingests documents (primarily faxes) from referring providers, reads and extracts structured clinical data using a proprietary vision-language model called RaeLM, checks eligibility across 1,200+ payers, applies payer criteria to qualify patients for prior authorization, submits PAs, and routes patients through to scheduling — all without requiring referring providers to change how they work (Tennr website, Fortune).
The workflow begins when a referral document arrives (usually by fax). Tennr’s AI classifies the document, handles complex edge cases (10 patients on one document, 10 documents for one patient), extracts patient information (name, diagnosis codes, ordering provider, insurance), populates it into the receiving provider’s EHR, runs eligibility checks, maps diagnosis and procedure codes against 8,000+ payer criteria sets to determine PA requirements, flags missing documentation before submission, submits PAs, and automates outreach to referring providers for missing information and to patients for scheduling (Fierce Healthcare).
“Patient routing” in Tennr’s context means operational triage: after intake and clinical qualification, the system surfaces which patients are ready to schedule, which are stuck (waiting on documentation, PA, or eligibility), and presents them in priority order. The Tennr Network (launched June 2025) adds a coordination layer giving referring providers, receiving providers, and patients real-time visibility into referral status (PR Newswire).
Voice calling is a secondary, additive capability — Tennr makes automated phone calls to payers for complex benefits investigations that cannot be resolved via digital clearinghouse, and is building out patient outreach calling. But the core product is document AI, not conversational voice AI.
Competitive Positioning
Tennr operates in a different product category from Infinitus, SuperDial, and Prosper AI. Those companies automate payer phone calls (voice AI); Tennr automates document processing and referral intake (document AI). They sit on opposite sides of the same administrative transaction: Infinitus calls payers on behalf of a pharma hub to check PA status, while Tennr processes the referral documents on the receiving specialty provider’s side. The two are complementary, not directly competitive, when viewed through a pharma lens.
Tennr competes more directly with legacy referral management (ReferralMD), DME-focused automation (Notable Systems), clearinghouse platforms (Waystar, Availity), and EHR-native referral tools (Epic, Oracle Health). Its primary moat is the RaeLM vision-language model trained on 100M+ healthcare documents — a proprietary dataset competitors cannot easily replicate (Lightspeed).
Tennr is also the most richly funded and valued company in this batch ($162M raised, $605M valuation), reflecting its broader product scope (referral-to-revenue platform, not just PA automation) and rapid revenue growth (tripled in 8 months).
Recent Developments (2024-2026)
- March 2024: Series A ($18M) led by a16z (Forbes)
- October 2024: Series B ($37M) led by Lightspeed; Multi-Patient model and checkbox reader breakthroughs (GlobeNewswire)
- March 2025: Launched Workspace (intake team dashboard) and Eligibility & Benefits Management modules (PR Newswire)
- June 2025: Series C ($101M) led by IVP at $605M valuation; Tennr Network launched; had not spent Series B capital when Series C closed (Fierce Healthcare)
- October 2025: Named KLAS Research Top 20 Emerging Solutions for 2025 (PR Newswire)
- November 2025: Hired Maulik Shah (ex-Epic, Huron, Ambience) as GM of Health Systems — signaling intentional push into larger accounts (PR Newswire)
- February 2026: Hired Dr. William H. Morris (former CMO of Google Cloud Healthcare, built Cleveland Clinic’s eICU) as Chief Medical Officer (PR Newswire)
Client Types
Tennr’s primary buyers are specialty treatment providers that depend on inbound referrals. The deepest vertical is DME/HME suppliers (NEB Medical, Eastern MedTech, Norco Inc., MGA Homecare, and approximately 10 other named DME customers), followed by orthopedics (Rothman Orthopaedics, Synergy Orthopedics), behavioral health (Talkiatry), and sleep medicine (Tennr customer stories). The company is actively expanding into health systems with dedicated GM and CMO hires.
Tennr does not sell to pharma manufacturers directly. However, its adjacency is significant: DME suppliers handling specialty respiratory equipment and CGM devices overlap with specialty pharma distribution channels, and as Tennr expands into oncology, infusion, and other specialty care settings, it will increasingly touch workflows where branded pharmaceutical products generate PA requirements.
Technology Platform
Tennr’s core AI is RaeLM (proprietary vision-language model) trained on 100M+ anonymized healthcare documents, 2.3 billion data fields, 8,000 payer criteria sets, and “the world’s largest dataset of labeled checkboxes” (Fierce Healthcare). RaeLM is built by fine-tuning open-source foundation models (Mistral, Llama) on Tennr’s proprietary dataset — the data moat, not the base model, is the defensible asset. The platform claims 99.8% extraction accuracy (LinkedIn). Tennr integrates with 30+ EMR systems with 50+ FTEs dedicated full-time to EHR integrations — all built in-house. Eligibility verification uses Stedi’s Real-Time Eligibility API across 1,200+ payers (Stedi). Automation confidence is tunable: 99% threshold = ~20% fully automated; 97% threshold = ~50% automated.
Financial Context
| Metric | Value |
|---|---|
| Total funding | $162M |
| Latest round | Series C, $101M (June 2025, led by IVP) |
| Valuation | $605M (Fierce Healthcare) |
| Revenue | Eight figures ARR; tripled Oct 2024 to June 2025 |
| Revenue growth | +230% YoY as of early 2026 (YouTube / CareTalk) |
| Employees | 256 (Jan 2026) |
| Documents processed | 10M+/month |
| Revenue stage | Scaling rapidly — approaching growth-stage metrics |
| Key investors | IVP, a16z, Lightspeed, GV, ICONIQ Growth, Foundation Capital, Frank Slootman |
Analyst Observations
Defensibility: Strong. RaeLM’s proprietary training dataset (100M+ healthcare documents, 8,000 payer criteria sets) is a genuine data moat that competitors cannot easily replicate. The 50+ FTE investment in EHR integrations creates high switching costs. The Tennr Network adds potential network effects as more providers join. Revenue tripling in 8 months while not spending Series B capital suggests strong unit economics.
Commoditization risk: Lower than voice AI competitors. Document AI for messy healthcare documents (handwriting, faxes, checkboxes) is technically harder than voice AI for phone calls, and Tennr’s proprietary dataset provides a durable advantage. However, general-purpose vision-language models are improving rapidly, which could narrow Tennr’s performance gap over time.
Acquisition target potential: Very high. Tennr is one of the hottest healthcare AI companies in the market. Natural acquirers include Epic (embed referral intelligence natively in the dominant EHR), McKesson (complement CoverMyMeds’ ePA with document AI), UnitedHealth Group/Optum (referral-to-revenue platform for Optum practices), Flatiron Health (specialty care data platform), or a large health system investor (Memorial Hermann invested in Infinitus; similar logic applies). The $605M valuation makes this a significant acquisition (likely $1B+ price tag for a premium), limiting buyers to strategic acquirers with healthcare portfolios.
What differentiates Tennr: It is playing a fundamentally different game than voice AI PA companies. Tennr’s thesis — that the referral is where patients get lost, and document processing is the bottleneck — is broader than “automate the payer phone call.” The Tennr Network’s referral visibility layer has the potential to become infrastructure if widely adopted. The YC to $605M valuation in ~2 years (Seed to Series C) is one of the fastest trajectories in healthcare AI.
Therapeutic Focus
broad/all
Target Customers
Specialty pharmacies, infusion centers, imaging centers, home health agencies, DME suppliers, health systems (referral-based providers), orthopedics, behavioral health
Sources
Similar Vendors
100ms
Voice AI agents automating patient access workflows for pharma and specialty pharmacy to cut delays and boost adherence.
AccessSync
Integrated platform unifies payer data and tools to empower biopharma field teams for precise market access execution.
Agadia Systems
AI-powered utilization management platform automating prior authorization for 100M+ covered lives across 55+ health plan and PBM customers, with an emerging specialty drug ePA portal for pharma.
Apothesource
Custom software solutions modernizing healthcare IT for providers with pharmacy and government expertise.
Argano
AI-driven consultancy delivering high-performance operations, GTN management, and analytics for pharma in complex regulatory environments.
Asepha
AI agents automating pharmacy workflows to accelerate specialty medication access and cut admin time by 80%.